Nanophase Reports Third Quarter 2009 Financial Results With Improved Margins and Reduced Operating Losses

October 28, 2009 4:00 PM EDT

ROMEOVILLE, Ill., Oct. 28 /PRNewswire-FirstCall/ -- Nanophase Technologies Corporation (Nasdaq: NANX), a technology leader in nanomaterials and advanced nanoengineered products, today reported financial results for its third quarter ended September 30, 2009.

Third Quarter

Revenue for the third quarter of 2009 was $1.7 million, compared to $2.1 million for the same period in 2008.

"While economic conditions have affected revenue in 2009, we are pleased to see a revenue increase on a quarter-to-quarter basis," commented Nanophase CEO and President Jess Jankowski. "It is difficult to predict when the economy will right itself, yet the overall disposition of the financial community and industry leaders seems more positive than it has been for some time."

"We are beginning to see the benefits of our new, leaner business strategy as gross margins (as a percentage of revenue) increased by 93 percent over the comparable third quarter in 2008, a positive indication that we are heading in the right direction," added Jankowski.

The net loss for the quarter was $0.9 million, or a loss of $0.04 per share, compared to a net loss of $2.8 million, or a loss of $0.13 per share, for the third quarter of 2008. Of the $2.8 million loss in the third quarter of 2008, $1.2 million were operating losses and $1.6 million were attributed to severance charges.

Jankowski continued, "We are seeing positive results from our structural efficiencies. While revenue was down from the prior year, the net outcome was a $0.3 million improvement. Our strategy is just beginning to demonstrate the results we expect to see in the coming quarters."

"Our customers remain concerned about inventory levels as economic recovery remains tenuous. We expect revenue in the coming quarter to be inline with the previous three quarters, base-lining our expectations at around $1.2M. We feel confident that our development of new customers and markets will position the company for growth in 2010, even if the overall economy remains sluggish."

Jankowski will be discussing the company's third quarter performance and future prospects during today's conference call. Shareholders and members of the investing community are encouraged to participate.

Third Quarter Financial Results Conference Call

Nanophase has scheduled its quarterly conference call for October 28, 2009, at 4:00 p.m. CDT (5:00 p.m. EDT), which will be hosted by Jess Jankowski, president and CEO. To participate in the call you may dial toll-free 800-344-8034, or 785-830-1990 for international callers. The conference call identification is 7NANOPHASE. The call may also be accessed through the company's website, www.nanophase.com, by clicking on the link under News Center and Calendar of Events. If you are unable to attend, a replay will be available through November 4, 2009, by dialing toll-free 800-283-4593, or 402-220-0872, or by logging onto the company's website and following the directions above.

Use of Non-GAAP Financial Information

Nanophase believes that the presentation of results excluding certain items, including severance charges and non-cash equity compensation charges, provides meaningful supplemental information to both management and investors, facilitating the evaluation of performance across reporting periods. The Company uses these non-GAAP measures for internal planning and reporting purposes. These non-GAAP measures are not in accordance with, or an alternative for, generally accepted accounting principles and may be different from non-GAAP measures used by other companies. The presentation of this additional information is not meant to be considered in isolation, or as a substitute for net income, or net income per share prepared in accordance with generally accepted accounting principles.

About Nanophase Technologies

Nanophase Technologies Corporation (NANX), www.nanophase.com, is a leader in nanomaterials technologies and provides nanoengineered products and solutions for multiple industrial product applications. Using a platform of patented and proprietary integrated nanomaterial technologies, the Company creates products with unique performance attributes from two ISO 9001:2000 and ISO 14001 facilities. Nanophase delivers commercial quantity and quality nanoparticles, coated nanoparticles, and nanoparticle dispersions in a variety of media.

Forward-Looking Statements

This press release contains words such as "expects," "shall," "will," , "believes," and similar expressions that are intended to identify forward-looking statements within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995. Such statements in this announcement are made based on the Company's current beliefs, known events and circumstances at the time of publication, and as such, are subject in the future to unforeseen risks and uncertainties that could cause the Company's results of operations, performance and achievements to differ materially from current expectations expressed in, or implied by, these forward-looking statements. These risks and uncertainties include, without limitation, the following: a decision by a customer to cancel a purchase order or supply agreement in light of the Company's dependence on a limited number of key customers; uncertain demand for, and acceptance of, the Company's nanocrystalline materials; the Company's manufacturing capacity and product mix flexibility in light of customer demand; the Company's limited marketing experience; changes in development and distribution relationships; the impact of competitive products and technologies; the Company's dependence on patents and protection of proprietary information; the resolution of litigation in which the Company may become involved; and other factors described in the Company's Form 10-K filed March 25, 2009. In addition, the Company's forward-looking statements could be affected by general industry and market conditions and growth rates. Except as required by federal securities laws, the Company undertakes no obligation to update or revise these forward-looking statements to reflect new events, uncertainties or other contingencies.

                                    Tables follow



                          NANOPHASE TECHNOLOGIES CORPORATION

                                    BALANCE SHEETS

                                     (Unaudited)


                                             September 30,    December 31,
                   ASSETS                         2009            2008
                                                  ----            ----


    Current assets:
      Cash and cash equivalents               $1,141,253        $723,069
      Investments                              1,879,168       6,908,888
      Trade accounts receivable, less
       allowance for doubtful accounts
        of $9,000 on September
         30, 2009 and December 31, 2008          784,738       1,092,125
      Other receivable                                 -           7,749
      Inventories, net                         1,215,858       1,154,207
      Prepaid expenses and other
       current assets                            352,168         482,452
                                                 -------         -------
        Total current assets                   5,373,185      10,368,490

      Investments                              5,340,000       5,340,000
      Equipment and leasehold
       improvements, net                       5,824,031       6,651,842
      Other assets, net                           40,087          39,765
                                                  ------          ------
                                             $16,577,303     $22,400,097
                                             ===========     ===========

               LIABILITIES AND STOCKHOLDERS' EQUITY
    Current liabilities:
      Current portion of capital lease
       obligations                                 8,277          22,211
      Current portion of deferred
       other revenue                                   -          74,243
      Current portion of long term
       debt, less current
       maturities and debt discount                    -       1,570,346
      Accounts payable                           381,103         356,853
      Accrued expenses                         1,359,984       1,493,262
      Accrued severance                          179,403         541,014
                                                 -------         -------
        Total current liabilities              1,928,767       4,057,929
                                               ---------       ---------

      Long-term portion of capital
       lease obligations                           2,940           9,219
                                                   -----           -----
                                                   2,940           9,219
                                                   -----           -----

    Contingent liabilities:                            -               -

    Stockholders' equity:
      Preferred stock, $.01 par value,
       24,088 shares authorized and
        no shares issued and
         outstanding                                   -               -
      Common stock, $.01 par value,
       30,000,000 shares authorized;
       21,204,162 and 21,188,912 shares issued
       and outstanding on September 30, 2009 and
        December 31, 2008, respectively          212,042         211,889
      Additional paid-in capital              92,132,943      91,597,529
      Accumulated deficit                    (77,699,389)    (73,476,469)
                                             -----------     -----------
        Total stockholders' equity            14,645,596      18,332,949
                                              ----------      ----------
                                             $16,577,303     $22,400,097
                                             ===========     ===========



                       NANOPHASE TECHNOLOGIES CORPORATION

                            STATEMENTS OF OPERATIONS

                                  (Unaudited)

                            Three months ended        Nine months ended
                              September 30,             September 30,
                                     As Adjusted               As Adjusted
                             2009        2008         2009         2008
                             ----        ----         ----         ----
    Revenue:
      Product revenue,
       net               $1,633,653   $1,967,061   $4,431,199   $7,721,408
      Other revenue          87,828      111,906      306,103      356,072
                             ------      -------      -------      -------
        Total
         revenue          1,721,481    2,078,967    4,737,302    8,077,480

    Operating expense:
      Cost of revenue     1,264,058    1,789,049    4,009,345    5,625,533
                          ---------    ---------    ---------    ---------
        Gross Profit        457,423      289,918      727,957    2,451,947

      Research and
       development
       expense              433,593      443,241    1,218,712    1,298,175
      Selling, general
       and administrative
       expense              913,456    1,113,156    2,964,966    4,217,542
      Severance charges           -    1,578,859      794,069    1,578,859
                            -------    ---------      -------    ---------
    Loss from
     operations            (889,626)  (2,845,338)  (4,249,790)  (4,642,629)
    Interest income          15,990       82,301       74,284      330,311
    Interest expense         (2,076)     (29,410)     (35,362)    (100,969)
    Other, net                    -       (8,651)     (12,052)      (8,494)
                            -------       ------      -------       ------
    Loss before
     provision for
     income taxes          (875,712)  (2,801,098)  (4,222,920)  (4,421,781)
    Provision for
     income taxes                 -            -            -            -
                            -------    ---------    ---------    ---------
    Net loss              $(875,712) $(2,801,098) $(4,222,920) $(4,421,781)
                          =========  ===========  ===========  ===========


    Net loss per share-
     basic and diluted       $(0.04)      $(0.13)      $(0.20)      $(0.21)
                             ======       ======       ======       ======

    Weighted average
     number of common
     shares outstanding  21,204,162   21,150,568   21,201,927   21,129,369
                         ==========   ==========   ==========   ==========




                       NANOPHASE TECHNOLOGIES CORPORATION

                  STATEMENTS OF OPERATIONS - EXPANDED SCHEDULE

                                  (Unaudited)

                            Three months ended        Nine months ended
                              September 30,             September 30,
                                     As Adjusted               As Adjusted
                             2009        2008          2009        2008
                             ----        ----          ----        ----
    Revenue:
      Product revenue,
       net               $1,633,653   $1,967,061   $4,431,199   $7,721,408
      Other revenue          87,828      111,906      306,103      356,072
                             ------      -------      -------      -------
        Total revenue     1,721,481    2,078,967    4,737,302    8,077,480

    Operating expense:
      Cost of revenue
       detail:
      Depreciation          227,092      252,172      713,160      730,792
      Non-Cash equity
       compensation           6,699       21,949       33,115       58,885
      Other costs of
       revenue            1,030,267    1,514,928    3,263,070    4,835,856
                          ---------    ---------    ---------    ---------
        Cost of revenue   1,264,058    1,789,049    4,009,345    5,625,533
                          ---------    ---------    ---------    ---------
          Gross profit      457,423      289,918      727,957    2,451,947

      Research and
       Development
       expense detail:
      Depreciation           57,271       59,886      171,541      177,661
      Non-Cash equity
       compensation          28,818       40,031       76,840      109,344
      Other research
       and development
       expense              347,504      343,324      970,331    1,011,170
                            -------      -------      -------    ---------
        Research and
         development
         expense            433,593      443,241    1,218,712    1,298,175

      Selling, general and
       administrative
       expense detail:
      Depreciation and
       amortization          19,352       15,759       59,079       45,464
      Non-Cash equity
       compensation          72,138       96,299      228,571      422,931
      Trademark abandonment
       charge                     -       37,214            -       37,214
      Other selling,
       general and
       administrative
       expense              821,966      963,884    2,677,316    3,711,933
                            -------      -------    ---------    ---------
        Selling,
         general and
         administrative
         expense            913,456    1,113,156    2,964,966    4,217,542
        Severance
         charges                  -    1,578,859      794,069    1,578,859
                            -------    ---------      -------    ---------
    Loss from
     operations            (889,626)  (2,845,338)  (4,249,790)  (4,642,629)
    Interest income          15,990       82,301       74,284      330,311
    Interest expense         (2,076)     (29,410)     (35,362)    (100,969)
    Other, net                    -       (8,651)     (12,052)      (8,494)
                              -----       ------      -------       ------
    Loss before
     provision for
     income taxes          (875,712)  (2,801,098)  (4,222,920)  (4,421,781)
    Provision for
     income taxes                 -            -            -            -
                            -------    ---------    ---------    ---------
    Net loss              $(875,712) $(2,801,098) $(4,222,920) $(4,421,781)
                          =========  ===========  ===========  ===========

    Non-GAAP Disclosure (see note regarding Non-GAAP disclosures):
    ----------------------------------------------------------------------
      Addback Interest,
       net                  (13,914)     (52,891)     (38,922)    (229,342)
      Addback Other
       Deferred Revenue     (10,608)     (31,818)     (74,243)     (95,454)
      Addback
       Depreciation/
       Amortization         303,715      327,817      943,780      953,917
      Addback
       Abandonment of
       Trademarks                 -       37,214            -       37,214
      Addback Severance
       Charge                     -    1,578,859      794,069    1,578,859
      Addback Non-Cash
       Equity
       Compensation         107,655      158,279      338,526      591,160
                            -------      -------      -------      -------

      Adjusted EBITDA     $(488,864)   $(783,638) $(2,259,710) $(1,585,427)
                          =========    =========  ===========  ===========

SOURCE Nanophase Technologies Corporation


Related Categories

Press Releases

Stocks Mentioned

NANX 0.85

-0.09 -9.57%
Volume: 32,246
Track NANX


Add Your Comment